This website uses cookies to enhance the user experience.
||
B

BIOMED CLUSTER AS912 971 880

Research
Limited company
Stasjonsveien 33A 0772 OSLO, Norge

BIOMED CLUSTER AS

Closed at August 29th, 2024, Voluntary liquidation
Konsulentvirksomhet innen forretningsutviklinger og kommersialisering av teknologi innen bioteknologi i både Asia og Norge, salg av biokjemiske reagenser og andre produkter for forskning og bioteknologi industri og annet som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender. Selskapet har som formål å tilbud konsultasjon til forretningsutvikling spesialt innen bioteknologi i både Asia og Norge, å kommersialisere bioteknologi og selge biokjemisks reagenser for forskning og bioteknologi industrien.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
TZ
Operation time
11 years
- Dec 23, 2013 to Aug 29, 2024
Type
Limited company
VAT registered
No
Number of employees
0

Financials

Total equity 2023
14,731
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
TZ
Chairman-
Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year20232022
Total operating income
0
0
Annual Total Result
0
-250
Total assets
18,583
18,583
Total liabilities
4,665
4,665
Total equity
14,731
14,731

P&L

Year20232022
Total operating income
0
0
Total operating costs
0
250
Operating result
0
-250
Financial income/costs
0
0
Profit before tax
0
-250
Total tax & extraordinary income/cost
0
0
Annual Total Result
0
-250

Balance overview

Year20232022
Total fixed assets
14,446
14,446
Total current assets
4,137
4,137
Total assets
18,583
18,583
Short term debt
0
0
Long term debt
4,665
4,665
Total liabilities
4,665
4,665
Contributed capital
14,731
14,731
Retained earnings
0
0
Total equity
14,731
14,731
Total equity and liabilities
19,396
19,396

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology